Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Int J Tuberc Lung Dis. 2019 Sep 1;23(9):1005–1011. doi: 10.5588/ijtld.18.0626

Table 2.

Rates of acute kidney injury according to the RIFLE classification (the two RIFLE stages are mutually exclusive)

RIFLE stages Total population
(n = 147)
n (%)		 Kanamycin use
(n = 130)
n (%)		 Capreomycin use
(n = 17)
n (%)
Risk
 1.5× creatinine increase 3 (2) 2 (2) 1 (6)
 25% GFR decrease 65 (44) 57 (44) 8 (47)
 Either 65 (44) 57 (44) 8 (47)
Injury
 2× creatinine increase 2 (1) 2 (2) 0 (0)
 50% GFR decrease 15 (10) 14 (11) 1 (6)
 Either 15 (10) 14 (11) 1 (6)

RIFLE = Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease; GFR = glomerular filtration rate.